Nothing Special   »   [go: up one dir, main page]

JPH0413653A - Production of alpha-amino-beta-hydroxyvaleric acid - Google Patents

Production of alpha-amino-beta-hydroxyvaleric acid

Info

Publication number
JPH0413653A
JPH0413653A JP11811690A JP11811690A JPH0413653A JP H0413653 A JPH0413653 A JP H0413653A JP 11811690 A JP11811690 A JP 11811690A JP 11811690 A JP11811690 A JP 11811690A JP H0413653 A JPH0413653 A JP H0413653A
Authority
JP
Japan
Prior art keywords
acid
oxazoline
alkali
reaction
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11811690A
Other languages
Japanese (ja)
Inventor
Ikuko Okamura
岡村 育子
Hiroshi Honda
洋 本田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Synthetic Chemical Industry Co Ltd
Original Assignee
Nippon Synthetic Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Synthetic Chemical Industry Co Ltd filed Critical Nippon Synthetic Chemical Industry Co Ltd
Priority to JP11811690A priority Critical patent/JPH0413653A/en
Publication of JPH0413653A publication Critical patent/JPH0413653A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To obtain the subject compound which is a chemical, having a high threonine production activity and useful for breeding strains by keeping the reaction temperature within a specific range in carrying out ring opening reaction of the oxazoline ring in a 5-ethyl-4-alkoxycarbonyl-2-oxazoline with an acid, etc. CONSTITUTION:A 5-ethyl-4-alkoxycarbonyl-2-oxazoline is subjected to ring opening reaction of the oxazoline ring with an acid or an alkali while keeping the reaction temperature within the range of 0-10 deg.C to afford the objective compound. A mineral acid such as hydrochloric acid or sulfuric acid, especially the hydrochloric acid is used as the acid in an amount of 20-70wt.%, preferably 40-50wt.% based on the oxazoline. Sodium hydroxide, etc., are used as the alkali in amount of 10-70wt.%, especially 40-50wt.%. In comparison of the acid with the alkali, the use of the acid provides a better yield of the objective compound than that of the alkali. The oxazoline which is a starting raw material is synthesized from an isocyanate and propionaldehyde.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、スレオニン生産活性が高い菌株を育種するた
めに有用なα−アミノ−β−ヒドロキシ吉草酸の製造法
に関するものである。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for producing α-amino-β-hydroxyvaleric acid, which is useful for breeding strains with high threonine-producing activity.

[従来の技術] α−アミノ−β−ヒドロキシ吉草酸(以下AHVと略す
る)は、スレオニン生産活性が高い菌株を育種するため
の薬剤として有用である。
[Prior Art] α-amino-β-hydroxyvaleric acid (hereinafter abbreviated as AHV) is useful as a drug for breeding bacterial strains with high threonine production activity.

即ち、AHVを加えた寒天培地で菌を増殖させると、ス
レオニン生産活性が高い菌株を得ることができる。
That is, by growing the bacteria on an agar medium containing AHV, a strain with high threonine production activity can be obtained.

上記のAHV製造法としては殆ど文献はなく、例えばN
−ビリビリデングリンネート銅永和物とプロピオンアル
デヒドをナトリウムメトキンド触媒の存在下で反応させ
る方法(BuL’L、CHEM、Soc、Jap、 、
47(5)、 1295(1974) )か示されてい
る。
There is almost no literature on the above AHV manufacturing method, for example, N
- A method for reacting bilibylidene grinnate copper ethosate with propionaldehyde in the presence of a sodium Metkind catalyst (BuL'L, CHEM, Soc, Jap,
47(5), 1295 (1974)).

又、A)IVと直接関連はしないがAHVの類縁化合物
として、イソシアネートとアセトアルデヒドを反応させ
、5−メチル−4−アルコキンカルボニル−2−オキサ
シリンを得、これを室温においてオキサゾリン開環反応
させ、α−アミノ−β−ヒドロキン酪酸(スレオニン)
を製造する方法(Agr、Biol、Chem、 、 
40.2045(1976) )か示されている。
Also, A) as a compound analogous to AHV but not directly related to IV, isocyanate and acetaldehyde are reacted to obtain 5-methyl-4-alcokynecarbonyl-2-oxacillin, which is subjected to an oxazoline ring-opening reaction at room temperature; α-amino-β-hydroquine butyric acid (threonine)
(Agr, Biol, Chem, ,
40.2045 (1976)).

[発明が解決しようとする課題] しかし、従来の方法では副生成物としてグリシジが10
%も混在する欠点がある。A)IV中にグリシジが混入
するとスレオニン生産活性の高い菌の増殖が抑えられ、
スレオニン生産性が格段に落ちてしまった菌しか得られ
ないのである。
[Problem to be solved by the invention] However, in the conventional method, glycidium is produced as a by-product.
% also has the disadvantage of being mixed. A) When glycidi is mixed into IV, the growth of bacteria with high threonine production activity is suppressed,
Only bacteria with significantly reduced threonine productivity can be obtained.

このためグリシンの副生のないAHVの製造方法の開発
が要求されるのである。
Therefore, there is a need to develop a method for producing AHV that does not produce glycine as a by-product.

[課題を解決するための手段] そこで、本発明者は上記の課題を解決するために鋭意研
究を行った結果、5−エチル−4−アルコキシカルボニ
ル−2−オキサゾリンを酸又はアルカリによりオキサゾ
リン開環反応を行い、AHVを製造する際に、反応温度
を0−10℃に保つことにより、グリシンの副生をほぼ
完全に抑えることが出来ることを見出し、本発明を完成
するに至った。
[Means for Solving the Problems] Therefore, as a result of intensive research in order to solve the above problems, the present inventors conducted oxazoline ring-opening of 5-ethyl-4-alkoxycarbonyl-2-oxazoline with acid or alkali. The present inventors have discovered that the by-product of glycine can be almost completely suppressed by maintaining the reaction temperature at 0 to 10° C. during the reaction to produce AHV, and have completed the present invention.

本発明の合成法の特徴は、5−エチル−4−アルコキシ
カルボニル−2−オキサシリン(以下単にオキサゾリン
と略す)の開環温度を0〜lθ℃に保つという点である
。このことによりグリシンの副生を抑えることができる
のである。
A feature of the synthesis method of the present invention is that the ring-opening temperature of 5-ethyl-4-alkoxycarbonyl-2-oxacillin (hereinafter simply referred to as oxazoline) is maintained at 0 to 1θ°C. This makes it possible to suppress the by-product of glycine.

以下、本発明の工程について詳細に説明する。Hereinafter, the steps of the present invention will be explained in detail.

まず、本発明の反応は次の如き反応式で示される。First, the reaction of the present invention is shown by the following reaction formula.

”         (mu、R1よア2.。I。” (mu, R1 yo a2..I.

出発原料であるオキサゾリンは、イソシアネートとプロ
ピオンアルデヒドを反応させることにより合成され、こ
の際のイソシアネートとプロピオンアルデヒドの反応比
は1:1〜I:5であり、好ましくは1;2である。
Oxazoline, which is a starting material, is synthesized by reacting isocyanate and propionaldehyde, and the reaction ratio of isocyanate and propionaldehyde is 1:1 to I:5, preferably 1:2.

オキサゾリンにおけるアルコキシル基とは、メトキシ基
、エトキシ基、プロポキシ基、ブトキシ基などであり、
通常炭素数が1〜4の範囲のものが好適である。
The alkoxyl group in oxazoline includes methoxy group, ethoxy group, propoxy group, butoxy group, etc.
Generally, those having a carbon number of 1 to 4 are suitable.

上記のオキサゾリンを0〜10℃の温度条件の下、酸又
はアルカリでオキサゾリンの開環反応を行う。開環温度
を0〜10℃の範囲内に保つと、グリシンの副生は0.
3%以下とほぼ完全に抑えられるが、0℃以下では反応
速度が急激に遅くなり、又10℃以上ではグリシンの副
生が大幅に増加するという欠点がある。
The above-mentioned oxazoline is subjected to a ring-opening reaction with an acid or an alkali at a temperature of 0 to 10°C. When the ring-opening temperature is maintained within the range of 0 to 10°C, the amount of glycine by-product is 0.
Although it can be almost completely suppressed to 3% or less, there are disadvantages in that the reaction rate slows down rapidly below 0°C, and the amount of glycine by-product increases significantly above 10°C.

ここでの酸とは塩酸、硫酸、硝酸などの鉱酸であり、塩
酸が実用的である。オキサゾリンに対する酸の使用量は
201量%〜70重量%であり、好ましくは40重量%
〜50重量%である。
The acids used here are mineral acids such as hydrochloric acid, sulfuric acid, and nitric acid, with hydrochloric acid being the most practical. The amount of acid used relative to oxazoline is 201% to 70% by weight, preferably 40% by weight.
~50% by weight.

又、アルカリとは水酸化ナトリウム、水酸化カリウム、
水酸化リチウムなどである。オキサゾリンに対するアル
カリの使用量は10重量%〜70重量%であり、好まし
くは40重量%〜50重量%である。
Also, alkalis include sodium hydroxide, potassium hydroxide,
Lithium hydroxide, etc. The amount of alkali used relative to the oxazoline is 10% to 70% by weight, preferably 40% to 50% by weight.

酸とアルカリを比へるとAHVの収率は酸の方が有利で
ある。
When comparing acids and alkalis, acids are more advantageous in terms of AHV yield.

溶媒としては通常水が用いられるが、必要であれば反応
に影響しない含水溶液なども使用可能である。
Water is usually used as the solvent, but if necessary, an aqueous solution that does not affect the reaction can also be used.

反応は酸又はアルカリを溶解した水溶液中にオキサゾリ
ンを加え、撹拌下に0〜10℃に保つだけで良い。
The reaction can be carried out simply by adding oxazoline to an aqueous solution containing an acid or alkali and maintaining the mixture at a temperature of 0 to 10° C. while stirring.

オキサゾリンは一括仕込みしても、分割仕込みしても、
連続仕込みしても良い。
Oxazoline can be prepared all at once or divided into parts.
You can prepare it continuously.

反応時間は0.5〜30時間が実用的であり、好ましく
は1〜5時間である。
A practical reaction time is 0.5 to 30 hours, preferably 1 to 5 hours.

得られる反応生成液は、常法に従って単離される。例え
ば、陽イオン交換樹脂カラム(H”型)に生成液を通過
させてAHVを樹脂に吸着させると共に、未反応物や不
純物を溶出除去する。吸着後、充分に水洗いしてからア
ンモニア水等のアルカリで吸着したAHVを溶出させる
。溶出液を減圧下で濃縮した後、水−エタノールを加え
ることにより再結晶を行いAHVを単離する。
The resulting reaction product liquid is isolated according to a conventional method. For example, the product solution is passed through a cation exchange resin column (H" type) to adsorb AHV to the resin, and unreacted substances and impurities are eluted and removed. After adsorption, it is thoroughly washed with water, and then ammonia water etc. The adsorbed AHV is eluted with an alkali.The eluate is concentrated under reduced pressure, and then recrystallized by adding water-ethanol to isolate the AHV.

本発明の方法においては、オキサゾリンの開環の際に蟻
酸か副生されるが、これは反応生成液を濃縮する際に水
と共に留去される。
In the method of the present invention, formic acid is produced as a by-product during ring opening of oxazoline, and this is distilled off together with water when the reaction product solution is concentrated.

かくして得られたAHVは収率の点ではやや低めである
が、グリシンの副生率を03%とほぼ完全に抑えること
が出来、スレオニン生産活性の高い菌株を育種するAH
Vの有効性は充分に期待出来る。
Although the yield of the AHV obtained in this way is somewhat low, the by-product rate of glycine can be almost completely suppressed to 0.3%, making it possible to breed AH strains with high threonine production activity.
The effectiveness of V can be fully expected.

[作 用コ 本発明ではAHVを合成する際、オキサゾリンを開環す
る反応温度を0〜10℃に保つことによって、副生成物
であるグリシンの副生率を抑えることが出来る。
[Function] In the present invention, when synthesizing AHV, by keeping the reaction temperature for ring-opening oxazoline at 0 to 10°C, the rate of by-product glycine can be suppressed.

[実施例] 以下、実施例を挙げて本発明を更に具体的に説明する。[Example] Hereinafter, the present invention will be explained in more detail with reference to Examples.

実施例1 2規定の塩酸220+nlを0〜5℃に冷却し、この温
度を保ちつつオキサゾリン409を徐々に添加した。更
に0〜5℃を保ちながら、3時間撹拌開環反応を行った
Example 1 220+nl of 2N hydrochloric acid was cooled to 0 to 5°C, and oxazoline 409 was gradually added while maintaining this temperature. Further, the ring-opening reaction was carried out with stirring for 3 hours while maintaining the temperature at 0 to 5°C.

反応終了後、陽イオン交換樹脂カラム(H°型)に通過
させ、カラム内を水で充分洗浄した。次に5%アンモニ
ア水溶液で吸着したAHVを溶出し、得られた溶出液を
減圧下で濃縮した。濃縮物に水−エタノール溶液500
1を加え再結晶を行うと11.39のAHVが得られた
After the reaction was completed, the mixture was passed through a cation exchange resin column (H° type), and the inside of the column was thoroughly washed with water. Next, the adsorbed AHV was eluted with a 5% ammonia aqueous solution, and the resulting eluate was concentrated under reduced pressure. Concentrate water-ethanol solution 500%
When recrystallization was performed by adding 1, an AHV of 11.39 was obtained.

次にこのAHVを高速液体クロマトグラフィーで分析し
たところ、グリシンの副生率は0,3%でしかなかった
Next, this AHV was analyzed by high performance liquid chromatography, and the by-product rate of glycine was only 0.3%.

実施例2 実施例1において反応温度を5〜10℃とした以外は同
じ条件下で反応を行った。グリシンの副生率は0.5%
であった。
Example 2 The reaction was carried out under the same conditions as in Example 1 except that the reaction temperature was 5 to 10°C. Glycine by-product rate is 0.5%
Met.

対照例1 実施例1において反応温度を15℃とした以外は同じ条
件下で反応を行った。グリシンの副生率は5%であった
Control Example 1 The reaction was carried out under the same conditions as in Example 1 except that the reaction temperature was 15°C. The by-product rate of glycine was 5%.

対照例2 実施例Iにおいて反応温度を30℃とした以外は同じ条
件下で反応を行った。グリシンの副生率は10%であっ
た。
Control Example 2 The reaction was carried out under the same conditions as in Example I except that the reaction temperature was 30°C. The by-product rate of glycine was 10%.

[効 果] 前記の如く、本発明の製造法はAHVを製造する際、5
−エチル−4−エトキシカルボニル−2−オキサシリン
の開環温度を0〜10℃に保つことにより、副生成物で
あるグリシンの生成が抑えられるという効果を有する。
[Effect] As mentioned above, the production method of the present invention has 5 effects when producing AHV.
By keeping the ring-opening temperature of -ethyl-4-ethoxycarbonyl-2-oxacillin at 0 to 10°C, it has the effect of suppressing the production of glycine as a by-product.

Claims (1)

【特許請求の範囲】[Claims] 5−エチル−4−アルコキシカルボニル−2−オキサゾ
リンを酸又はアルカリによりオキサゾリン開環反応を行
う際、反応温度を0〜10℃に保つことを特徴とするα
−アミノ−β−ヒドロキシ吉草酸の製造法。
α characterized in that when carrying out the oxazoline ring-opening reaction of 5-ethyl-4-alkoxycarbonyl-2-oxazoline with an acid or alkali, the reaction temperature is maintained at 0 to 10°C.
-Production method of amino-β-hydroxyvaleric acid.
JP11811690A 1990-05-07 1990-05-07 Production of alpha-amino-beta-hydroxyvaleric acid Pending JPH0413653A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11811690A JPH0413653A (en) 1990-05-07 1990-05-07 Production of alpha-amino-beta-hydroxyvaleric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11811690A JPH0413653A (en) 1990-05-07 1990-05-07 Production of alpha-amino-beta-hydroxyvaleric acid

Publications (1)

Publication Number Publication Date
JPH0413653A true JPH0413653A (en) 1992-01-17

Family

ID=14728427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11811690A Pending JPH0413653A (en) 1990-05-07 1990-05-07 Production of alpha-amino-beta-hydroxyvaleric acid

Country Status (1)

Country Link
JP (1) JPH0413653A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4858659B2 (en) * 2010-01-28 2012-01-18 住友金属工業株式会社 Heat treatment method for metal tube for nuclear power plant, batch type vacuum heat treatment furnace used therefor, and metal tube for nuclear power plant processed thereby
WO2013145583A1 (en) 2012-03-26 2013-10-03 新日鐵住金株式会社 Method for heat-treating metal pipes, metal pipe, and heat treatment furnace
US8739610B2 (en) 2008-10-16 2014-06-03 Shimadzu Corporation Sample injection port and auto-sampler having the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8739610B2 (en) 2008-10-16 2014-06-03 Shimadzu Corporation Sample injection port and auto-sampler having the same
JP4858659B2 (en) * 2010-01-28 2012-01-18 住友金属工業株式会社 Heat treatment method for metal tube for nuclear power plant, batch type vacuum heat treatment furnace used therefor, and metal tube for nuclear power plant processed thereby
WO2013145583A1 (en) 2012-03-26 2013-10-03 新日鐵住金株式会社 Method for heat-treating metal pipes, metal pipe, and heat treatment furnace
KR20160113744A (en) 2012-03-26 2016-09-30 신닛테츠스미킨 카부시키카이샤 Method for heat-treating metal pipes, metal pipe, and heat treatment furnace
US9745642B2 (en) 2012-03-26 2017-08-29 Nippon Steel & Sumitomo Metal Corporation Method for heat treating a metal tube or pipe, metal tube or pipe, and heat treatment furnace

Similar Documents

Publication Publication Date Title
JPH09511991A (en) Donkey platinum trihydrate
JPH0413653A (en) Production of alpha-amino-beta-hydroxyvaleric acid
JP3874820B2 (en) Method for producing taurine analogs
JPS6310752A (en) Production of trans-4-cyanocyclohexane-1-carboxylic acid
JPS606958B2 (en) Antibiotic purification method
CN110437257B (en) Preparation method of ceftizoxime intermediate 7-ANCA
CN109096148B (en) Method for preparing vorinostat by using modified mesoporous material through one-pot method
CN108707093A (en) A kind of synthetic method of guanidine compound
US2647894A (en) 2-chloroprocaine salt of penicillin omicron
CN117343021A (en) Preparation method of chlorophenophenazine
CN107955021A (en) A kind of production method of the Ceftriaxone Sodium of low impurity
JPS6046105B2 (en) Method for hydrolyzing cyano compounds
SU690002A1 (en) Method of preparing 4-methoxy-1,2-naphthoquinone
JPS62167754A (en) Production of cyanomethylthioacetic acids
JPH03287567A (en) Production of optically active quaternary ammonium salt
JPS62181289A (en) Production of n-glycolylneuraminic acid derivative
JPS5865257A (en) Preparation of l-threonine
CN116621838A (en) Butterfly acid active ester and synthesis method thereof
JPS59161366A (en) Thiadiazolinone compound
JPS63159339A (en) Production of sodium monochloroacetate
CN109336826A (en) A kind of chemical synthesis process of 2- hydroxybenzimidazole
BE721781A (en)
JPS58203999A (en) Preparation of glucose compound
JPH0413652A (en) Production of phenethylamine derivative
JPS61148155A (en) Production of d-or l-n6-carbobenzoxyllysine